App-Quantinova.ai

MEKiAUTO: A phase I/II open-label study of combination therapy with the MEK inhibitor cobimetinib, Immune-checkpoint blockade with atezolizumab, and the AUTOphagy inhibitor hydroxychloroquine in KRAS-mutated advanced malignancies.

Alexander Raufi - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

A phase I/II study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): Dose escalation results.

Brandon Lau - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

Hydroxychloroquine

ABCA3 deficiency in a newborn with respiratory failure

Mar�a Del Carmen L�pez - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Pulmonary surfactant metabolism dysfunction

Hydroxychloroquine

Hydroxychloroquine retinopathy: is screening necessary?

Anne Gobbett - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic retinopathy

Hydroxychloroquine

Early-onset neutropenia in rituximab treated rheumatoid arthritis patients: a case series

Chung Mun Alice Lin - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Primary biliary cirrhosis

Hydroxychloroquine

Gossypiboma causing SLE and dermatomyositis overlap

Liubov Borukhson - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Juvenile dermatomyositis

Hydroxychloroquine

A rare case of Sjögren's nephropathy

Constanta Amoasii - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Gastrointestinal bleeding

Hydroxychloroquine

Lung disease caused by non-null ABCA3 mutations: long-term follow-up

Effrosyni D. Manali - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Diabetic retinopathy

Hydroxychloroquine

COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality

Alex Niu - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Hematological malignancies

Hydroxychloroquine

Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients

Surbhi Warrior - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Vasodilation dysfunction

Hydroxychloroquine

Heparin Induced Thrombocytopenia in Patients with COVID-19

Surbhi Warrior - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Acute renal failure

Hydroxychloroquine

Edoxaban Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Hospitalized Patients with Atrial Fibrillation and COVID-19 Infection

Pvel E Olivera - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Arrhythmia

Hydroxychloroquine

Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry

Pilar Martnez - American Society of Hematology (ASH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Hydroxychloroquine

AKI in a Patient with COVID-19, G6PD Deficiency, Acetaminophen Overdose, and Methemoglobinemia: What a Broad Differential!

Morales-Alvarez M. Catalina - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Fulminant hepatic failure

Hydroxychloroquine

Thrombotic Microangiopathy (TMA) in a Patient with COVID-19

Flores Chang Bessy Suyin - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Thrombotic thrombocytopenic purpura

Hydroxychloroquine

A Case of Severe Thrombocytopenia in a Patient with COVID-19 Receiving Continuous Venovenous Hemodialysis

Me Hay Me - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Type 2 diabetes mellitus

Hydroxychloroquine

COVID-19 AKI to ESRD: A New Cohort of Dialysis-Dependent Patients

Chacko EricJ - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal insufficiency

Hydroxychloroquine

Severe Rhabdomyolysis in the Time of Coronavirus

Alvarez Torres Sergio�E. - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Dyspnea

Hydroxychloroquine

Extracorporeal Cytokine Reduction Using Oxiris Blood Purification in COVID-19

Hodgins Spencer - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Hydroxychloroquine

SARS-CoV-2 Infection in the Early Post-Transplant Period After a Living Donor Kidney Transplant

Shingare Ashay - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Dyspnea

Hydroxychloroquine

Filters

1151 Abstracts